Transcriptional Profiling of Azole-Resistant Candida parapsilosis Strains
- 1 July 2011
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 55 (7) , 3546-3556
Abstract
Herein we describe the changes in the gene expression profile ofCandida parapsilosisassociated with the acquisition of experimentally induced resistance to azole antifungal drugs. Three resistant strains ofC. parapsilosiswere obtained following prolongedin vitroexposure of a susceptible clinical isolate to constant concentrations of fluconazole, voriconazole, or posaconazole. We found that after incubation with fluconazole or voriconazole, strains became resistant to both azoles but not to posaconazole, although susceptibility to this azole decreased, whereas the strain incubated with posaconazole displayed resistance to the three azoles. The resistant strains obtained after exposure to fluconazole and to voriconazole have increased expression of the transcription factorMRR1, the major facilitator transporterMDR1, and several reductases and oxidoreductases. Interestingly, and similarly to what has been described inC. albicans, upregulation ofMRR1andMDR1is correlated with point mutations inMRR1in the resistant strains. The resistant strain obtained after exposure to posaconazole shows upregulation of two transcription factors (UPC2andNDT80) and increased expression of 13 genes involved in ergosterol biosynthesis. This is the first study addressing global molecular mechanisms underlying azole resistance inC. parapsilosis; the results suggest that similarly toC. albicans, tolerance to azoles involves the activation of efflux pumps and/or increased ergosterol synthesis.Keywords
This publication has 78 references indexed in Scilit:
- An A643T Mutation in the Transcription Factor Upc2p Causes Constitutive ERG11 Upregulation and Increased Fluconazole Resistance in Candida albicansAntimicrobial Agents and Chemotherapy, 2010
- Widespread occurrence of chromosomal aneuploidy following the routine production ofCandida albicansmutantsFEMS Yeast Research, 2009
- Evolution of pathogenicity and sexual reproduction in eight Candida genomesNature, 2009
- Gain-of-Function Mutations in the Transcription Factor MRR1 Are Responsible for Overexpression of the MDR1 Efflux Pump in Fluconazole-Resistant Candida dubliniensis StrainsAntimicrobial Agents and Chemotherapy, 2008
- Mutations in the multi‐drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole‐resistant Candida albicans strainsMolecular Microbiology, 2008
- Unexpected Link between Iron and Drug Resistance of Candida spp.: Iron Depletion Enhances Membrane Fluidity and Drug Diffusion, Leading to Drug-SusceptibleCellsAntimicrobial Agents and Chemotherapy, 2006
- Impact of Antimicrobial Dosing Regimen on Evolution of Drug Resistance In Vivo: Fluconazole andCandida albicansAntimicrobial Agents and Chemotherapy, 2006
- In Vivo Fluconazole Pharmacodynamics and Resistance Development in a Previously SusceptibleCandida albicansPopulation Examined by Microbiologic and Transcriptional ProfilingAntimicrobial Agents and Chemotherapy, 2006
- Genome-Wide Expression Profiling of the Response to Azole, Polyene, Echinocandin, and Pyrimidine Antifungal Agents inCandida albicansAntimicrobial Agents and Chemotherapy, 2005
- MUSCLE: multiple sequence alignment with high accuracy and high throughputNucleic Acids Research, 2004